KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Adaptive Biotechnologies (ADPT) Receivables - Other (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Receivables - Other for 8 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Receivables - Other rose 15.38% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 15.38% year-over-year, with the annual reading at $1.5 million for FY2025, 15.38% up from the prior year.
  • Receivables - Other hit $1.5 million in Q4 2025 for Adaptive Biotechnologies, roughly flat from $1.5 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $2.8 million in Q1 2021 to a low of $800000.0 in Q2 2022.
  • Historically, Receivables - Other has averaged $1.3 million across 5 years, with a median of $1.2 million in 2024.
  • Biggest five-year swings in Receivables - Other: soared 53.33% in 2021 and later tumbled 65.22% in 2022.
  • Year by year, Receivables - Other stood at $1.4 million in 2021, then plummeted by 42.86% to $800000.0 in 2022, then rose by 25.0% to $1.0 million in 2023, then increased by 30.0% to $1.3 million in 2024, then rose by 15.38% to $1.5 million in 2025.
  • Business Quant data shows Receivables - Other for ADPT at $1.5 million in Q4 2025, $1.5 million in Q3 2025, and $1.3 million in Q2 2025.